-
112-136-072
Allophycocyanin-AffiniPure F'2 Fragment Goat Anti-Rat IgG, F'2 Fragment Specific (min X Hu,Bov,Hrs Sr Prot), 0.5 mL
Price: $641.17List Price: $712.42F(ab')<sub>2</sub> fragment antibodies are generated by pepsin digestion of whole IgG antibodies to remove most of the Fc region while leaving some of the hinge region. F(ab')<sub>2</sub> fragments have two antigen-binding Fab portions -
112-136-075
Allophycocyanin-AffiniPure F'2 Fragment Goat Anti-Rat IgM, Chain Specific (min X Hu,Bov,Hrs Sr Prot), 0.5 mL
Price: $641.17List Price: $712.42F(ab')<sub>2</sub> fragment antibodies are generated by pepsin digestion of whole IgG antibodies to remove most of the Fc region while leaving some of the hinge region. F(ab')<sub>2</sub> fragments have two antigen-binding Fab portions -
E9569-406
Alm Retractor 4x4 Prong 4
Price: $25.08List Price: $35.83Floor Grade, Single Use Instrument -
A414297-100mg
Alobresib (C007B-021184)
Price: $2,082.74List Price: $2,314.16InformationAlobresib (GS-5829) Alobresib (GS-5829) is a novel BET inhibitor that represents a highly effective therapeutics agent against recurrent/chemotherapy-resistant USC-overexpressing c-Myc. Alobresib (GS-5829) inhibits CLL cell proliferation -
A414297-10mg
Alobresib (C007B-021185)
Price: $447.09List Price: $496.76InformationAlobresib (GS-5829) Alobresib (GS-5829) is a novel BET inhibitor that represents a highly effective therapeutics agent against recurrent/chemotherapy-resistant USC-overexpressing c-Myc. Alobresib (GS-5829) inhibits CLL cell proliferation -
A414297-250mg
Alobresib (C007B-021186)
Price: $4,686.90List Price: $5,207.66InformationAlobresib (GS-5829) Alobresib (GS-5829) is a novel BET inhibitor that represents a highly effective therapeutics agent against recurrent/chemotherapy-resistant USC-overexpressing c-Myc. Alobresib (GS-5829) inhibits CLL cell proliferation -
A414297-25mg
Alobresib (C007B-021187)
Price: $818.39List Price: $909.32InformationAlobresib (GS-5829) Alobresib (GS-5829) is a novel BET inhibitor that represents a highly effective therapeutics agent against recurrent/chemotherapy-resistant USC-overexpressing c-Myc. Alobresib (GS-5829) inhibits CLL cell proliferation -
A414297-500mg
Alobresib (C007B-021188)
Price: $8,436.51List Price: $9,373.90InformationAlobresib (GS-5829) Alobresib (GS-5829) is a novel BET inhibitor that represents a highly effective therapeutics agent against recurrent/chemotherapy-resistant USC-overexpressing c-Myc. Alobresib (GS-5829) inhibits CLL cell proliferation -
A414297-50mg
Alobresib (C007B-021189)
Price: $1,383.93List Price: $1,537.70InformationAlobresib (GS-5829) Alobresib (GS-5829) is a novel BET inhibitor that represents a highly effective therapeutics agent against recurrent/chemotherapy-resistant USC-overexpressing c-Myc. Alobresib (GS-5829) inhibits CLL cell proliferation -
A414297-5mg
Alobresib (C007B-021190)
Price: $271.37List Price: $301.53InformationAlobresib (GS-5829) Alobresib (GS-5829) is a novel BET inhibitor that represents a highly effective therapeutics agent against recurrent/chemotherapy-resistant USC-overexpressing c-Myc. Alobresib (GS-5829) inhibits CLL cell proliferation -
Ab179101-100ÎĽg
Alomfilimab (anti-ICOS) (C007B-328890)
Price: $190.21List Price: $211.35Alomfilimab (anti-ICOS) is a human immunoglobulin G1 (IgG1) kappa monoclonal antibody that recognizes inducible T-cell co-stimulator (ICOS: CD278), with potential immunomodulating and antineoplastic activities.Purity>:95% -
Ab179101-10mg
Alomfilimab (anti-ICOS) (C007B-328891)
Price: $2,618.06List Price: $2,908.96Alomfilimab (anti-ICOS) is a human immunoglobulin G1 (IgG1) kappa monoclonal antibody that recognizes inducible T-cell co-stimulator (ICOS: CD278), with potential immunomodulating and antineoplastic activities.Purity>:95%